Zoetis Inc. $ZTS Position Raised by Teachers Retirement System of The State of Kentucky

Key Points

• Teachers Retirement System of Kentucky increased its stake in Zoetis by 127.2% in Q4 to 80,198 shares valued at about $10.09 million, and institutional investors now own roughly 92.8% of the stock.
• Zoetis beat Q4 estimates (EPS $1.48 vs. $1.40; revenue $2.39B vs. $2.36B) and issued FY2026 guidance of $7.00–$7.10 EPS, while analysts remain mixed with a consensus rating of Hold and an average target of $152.25.
• The company declared a quarterly dividend of $0.53 (annualized $2.12, yield 1.8%), and the stock trades near $116.92 with a P/E of about 19.4 and a 52-week range of $113.29–$172.23.

Teachers Retirement System of The State of Kentucky raised its stake in Zoetis Inc. (NYSE:ZTS - Free Report) by 127.2% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 80,198 shares of the company's stock after buying an additional 44,894 shares during the quarter. Teachers Retirement System of The State of Kentucky's holdings in Zoetis were worth $10,091,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Halbert Hargrove Global Advisors LLC lifted its stake in Zoetis by 496.6% in the third quarter. Halbert Hargrove Global Advisors LLC now owns 173 shares of the company's stock valued at $25,000 after buying an additional 144 shares during the last quarter. Global Wealth Strategies & Associates bought a new stake in Zoetis in the fourth quarter valued at $25,000. KERR FINANCIAL PLANNING Corp bought a new stake in Zoetis in the third quarter valued at $31,000. Lodestone Wealth Management LLC bought a new stake in Zoetis in the fourth quarter valued at $30,000. Finally, Holos Integrated Wealth LLC bought a new stake in Zoetis in the fourth quarter valued at $32,000. 92.80% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

ZTS has been the topic of a number of recent analyst reports. BTIG Research restated a "buy" rating and set a $160.00 price objective on shares of Zoetis in a research note on Thursday, February 26th. Citigroup began coverage on shares of Zoetis in a research report on Wednesday, April 15th. They issued a "buy" rating and a $145.00 target price for the company. Piper Sandler restated a "neutral" rating and set a $135.00 price target (down from $190.00) on shares of Zoetis in a research report on Thursday, January 22nd. William Blair reaffirmed an "outperform" rating on shares of Zoetis in a research note on Monday, March 2nd. Finally, Weiss Ratings lowered shares of Zoetis from a "hold (c-)" rating to a "sell (d+)" rating in a research note on Friday, March 27th. Seven analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $152.25.

Zoetis Price Performance

NYSE:ZTS opened at $116.92 on Monday. The business's 50-day moving average price is $120.83 and its 200 day moving average price is $125.28. The firm has a market cap of $49.18 billion, a P/E ratio of 19.42, a PEG ratio of 1.78 and a beta of 0.98. Zoetis Inc. has a 52-week low of $113.29 and a 52-week high of $172.23. The company has a quick ratio of 1.94, a current ratio of 3.03 and a debt-to-equity ratio of 2.71.

Zoetis (NYSE:ZTS - Get Free Report) last released its earnings results on Thursday, February 12th. The company reported $1.48 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.40 by $0.08. The firm had revenue of $2.39 billion for the quarter, compared to analyst estimates of $2.36 billion. Zoetis had a return on equity of 62.02% and a net margin of 28.24%.Zoetis's revenue was up 3.0% compared to the same quarter last year. During the same period in the previous year, the company earned $1.40 earnings per share. Zoetis has set its FY 2026 guidance at 7.000-7.100 EPS. As a group, sell-side analysts predict that Zoetis Inc. will post 7.02 earnings per share for the current fiscal year.

Zoetis Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 2nd. Investors of record on Monday, April 20th will be paid a $0.53 dividend. The ex-dividend date of this dividend is Monday, April 20th. This represents a $2.12 dividend on an annualized basis and a yield of 1.8%. Zoetis's dividend payout ratio (DPR) is currently 35.22%.

About Zoetis

Zoetis Inc NYSE: ZTS is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company's offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.

Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.